The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Veterinary Drug Market Research Report 2024

Global Veterinary Drug Market Research Report 2024

Publishing Date : Jun, 2022

License Type :
 

Report Code : 1600831

No of Pages : 109

Synopsis
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

Due to the COVID-19 pandemic, the global Veterinary Drug market size is estimated to be worth US$ 23720 million in 2021 and is forecast to a readjusted size of US$ 34660 million by 2028 with a CAGR of 5.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Veterinary Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Veterinary Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.

This report focuses on Veterinary Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Veterinary Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan and Latin America, etc.

Global Veterinary Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Analgesics
  • Sedatives
  • Others

Segment by Application

  • Pets
  • Cattle
  • Poultry
  • Swine
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Zoetis
  • Elanco
  • Boehringer Ingelheim
  • Merck
  • Virbac
  • Ceva
  • Vetoquinol
  • Dechra
  • Norbrook
  • Phibro
  • Huvepharma
  • Hipra
  • Ouro Fino Saude
  • Cahic
  • Orion
  • Ringpu Biology
  • Nippon Zenyaku Kogyo
  • Farmavet-Pasteur
Index

1 Veterinary Drug Market Overview
1.1 Product Overview and Scope of Veterinary Drug
1.2 Veterinary Drug Segment by Type
1.2.1 Global Veterinary Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Veterinary Drug Segment by Application
1.3.1 Global Veterinary Drug Sales Comparison by Application: (2022-2028)
1.3.2 Pets
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Swine
1.3.6 Others
1.4 Global Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Veterinary Drug Revenue 2017-2028
1.4.2 Global Veterinary Drug Sales 2017-2028
1.4.3 Veterinary Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Drug Market Competition by Manufacturers
2.1 Global Veterinary Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Veterinary Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Veterinary Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Veterinary Drug Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Drug Market Competitive Situation and Trends
2.5.1 Veterinary Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Drug Players Market Share by Revenue
2.5.3 Global Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Drug Retrospective Market Scenario by Region
3.1 Global Veterinary Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Veterinary Drug Market Facts & Figures by Country
3.3.1 North America Veterinary Drug Sales by Country
3.3.2 North America Veterinary Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Veterinary Drug Market Facts & Figures by Country
3.4.1 Europe Veterinary Drug Sales by Country
3.4.2 Europe Veterinary Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Drug Sales by Region
3.5.2 Asia Pacific Veterinary Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Veterinary Drug Market Facts & Figures by Country
3.6.1 Latin America Veterinary Drug Sales by Country
3.6.2 Latin America Veterinary Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Drug Sales by Country
3.7.2 Middle East and Africa Veterinary Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Drug Historic Market Analysis by Type
4.1 Global Veterinary Drug Sales Market Share by Type (2017-2022)
4.2 Global Veterinary Drug Revenue Market Share by Type (2017-2022)
4.3 Global Veterinary Drug Price by Type (2017-2022)
5 Global Veterinary Drug Historic Market Analysis by Application
5.1 Global Veterinary Drug Sales Market Share by Application (2017-2022)
5.2 Global Veterinary Drug Revenue Market Share by Application (2017-2022)
5.3 Global Veterinary Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Zoetis Veterinary Drug Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Elanco
6.2.1 Elanco Corporation Information
6.2.2 Elanco Description and Business Overview
6.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Elanco Veterinary Drug Product Portfolio
6.2.5 Elanco Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Veterinary Drug Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ceva Veterinary Drug Product Portfolio
6.6.5 Ceva Recent Developments/Updates
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description and Business Overview
6.6.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Vetoquinol Veterinary Drug Product Portfolio
6.7.5 Vetoquinol Recent Developments/Updates
6.8 Dechra
6.8.1 Dechra Corporation Information
6.8.2 Dechra Description and Business Overview
6.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Dechra Veterinary Drug Product Portfolio
6.8.5 Dechra Recent Developments/Updates
6.9 Norbrook
6.9.1 Norbrook Corporation Information
6.9.2 Norbrook Description and Business Overview
6.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Norbrook Veterinary Drug Product Portfolio
6.9.5 Norbrook Recent Developments/Updates
6.10 Phibro
6.10.1 Phibro Corporation Information
6.10.2 Phibro Description and Business Overview
6.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Phibro Veterinary Drug Product Portfolio
6.10.5 Phibro Recent Developments/Updates
6.11 Huvepharma
6.11.1 Huvepharma Corporation Information
6.11.2 Huvepharma Veterinary Drug Description and Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments/Updates
6.12 Hipra
6.12.1 Hipra Corporation Information
6.12.2 Hipra Veterinary Drug Description and Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments/Updates
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Corporation Information
6.13.2 Ouro Fino Saude Veterinary Drug Description and Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments/Updates
6.14 CAHIC
6.14.1 CAHIC Corporation Information
6.14.2 CAHIC Veterinary Drug Description and Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments/Updates
6.15 Orion
6.15.1 Orion Corporation Information
6.15.2 Orion Veterinary Drug Description and Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments/Updates
6.16 Ringpu Biology
6.16.1 Ringpu Biology Corporation Information
6.16.2 Ringpu Biology Veterinary Drug Description and Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments/Updates
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Corporation Information
6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Description and Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments/Updates
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Corporation Information
6.18.2 Farmavet-Pasteur Veterinary Drug Description and Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments/Updates
7 Veterinary Drug Manufacturing Cost Analysis
7.1 Veterinary Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Drug
7.4 Veterinary Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Drug Distributors List
8.3 Veterinary Drug Customers
9 Veterinary Drug Market Dynamics
9.1 Veterinary Drug Industry Trends
9.2 Veterinary Drug Market Drivers
9.3 Veterinary Drug Market Challenges
9.4 Veterinary Drug Market Restraints
10 Global Market Forecast
10.1 Veterinary Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Veterinary Drug by Type (2023-2028)
10.2 Veterinary Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Veterinary Drug by Application (2023-2028)
10.3 Veterinary Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Veterinary Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Veterinary Drug Sales Growth Rate Comparison by Type (2022-2028) & (M Units) & (US$ Million)
Table 2. Global Veterinary Drug Sales Growth Rate Comparison by Application (2022-2028) & (M Units) & (US$ Million)
Table 3. Global Veterinary Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Veterinary Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Veterinary Drug Sales (M Units) of Key Manufacturers (2017-2022)
Table 6. Global Veterinary Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Veterinary Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Veterinary Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Veterinary Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Veterinary Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Veterinary Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Veterinary Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Veterinary Drug Sales by Region (2017-2022) & (M Units)
Table 16. Global Veterinary Drug Sales Market Share by Region (2017-2022)
Table 17. Global Veterinary Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Veterinary Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Veterinary Drug Sales by Country (2017-2022) & (M Units)
Table 20. North America Veterinary Drug Sales Market Share by Country (2017-2022)
Table 21. North America Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Veterinary Drug Sales by Country (2017-2022) & (M Units)
Table 24. Europe Veterinary Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Veterinary Drug Sales by Region (2017-2022) & (M Units)
Table 28. Asia Pacific Veterinary Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Veterinary Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Veterinary Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Veterinary Drug Sales by Country (2017-2022) & (M Units)
Table 32. Latin America Veterinary Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Veterinary Drug Sales by Country (2017-2022) & (M Units)
Table 36. Middle East and Africa Veterinary Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Veterinary Drug Sales by Type (2017-2022) & (M Units)
Table 40. Global Veterinary Drug Sales Market Share by Type (2017-2022)
Table 41. Global Veterinary Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Veterinary Drug Revenue Share by Type (2017-2022)
Table 43. Global Veterinary Drug Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Veterinary Drug Sales (M Units) by Application (2017-2022)
Table 45. Global Veterinary Drug Sales Market Share by Application (2017-2022)
Table 46. Global Veterinary Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Veterinary Drug Revenue Share by Application (2017-2022)
Table 48. Global Veterinary Drug Price by Application (2017-2022) & (USD/Unit)
Table 49. Zoetis Corporation Information
Table 50. Zoetis Description and Business Overview
Table 51. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Zoetis Veterinary Drug Product
Table 53. Zoetis Recent Developments/Updates
Table 54. Elanco Corporation Information
Table 55. Elanco Description and Business Overview
Table 56. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Elanco Veterinary Drug Product
Table 58. Elanco Recent Developments/Updates
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Description and Business Overview
Table 61. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Boehringer Ingelheim Veterinary Drug Product
Table 63. Boehringer Ingelheim Recent Developments/Updates
Table 64. Merck Corporation Information
Table 65. Merck Description and Business Overview
Table 66. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Merck Veterinary Drug Product
Table 68. Merck Recent Developments/Updates
Table 69. Virbac Corporation Information
Table 70. Virbac Description and Business Overview
Table 71. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Virbac Veterinary Drug Product
Table 73. Virbac Recent Developments/Updates
Table 74. Ceva Corporation Information
Table 75. Ceva Description and Business Overview
Table 76. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Ceva Veterinary Drug Product
Table 78. Ceva Recent Developments/Updates
Table 79. Vetoquinol Corporation Information
Table 80. Vetoquinol Description and Business Overview
Table 81. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Vetoquinol Veterinary Drug Product
Table 83. Vetoquinol Recent Developments/Updates
Table 84. Dechra Corporation Information
Table 85. Dechra Description and Business Overview
Table 86. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Dechra Veterinary Drug Product
Table 88. Dechra Recent Developments/Updates
Table 89. Norbrook Corporation Information
Table 90. Norbrook Description and Business Overview
Table 91. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Norbrook Veterinary Drug Product
Table 93. Norbrook Recent Developments/Updates
Table 94. Phibro Corporation Information
Table 95. Phibro Description and Business Overview
Table 96. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Phibro Veterinary Drug Product
Table 98. Phibro Recent Developments/Updates
Table 99. Huvepharma Corporation Information
Table 100. Huvepharma Description and Business Overview
Table 101. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Huvepharma Veterinary Drug Product
Table 103. Huvepharma Recent Developments/Updates
Table 104. Hipra Corporation Information
Table 105. Hipra Description and Business Overview
Table 106. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Hipra Veterinary Drug Product
Table 108. Hipra Recent Developments/Updates
Table 109. Ouro Fino Saude Corporation Information
Table 110. Ouro Fino Saude Description and Business Overview
Table 111. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Ouro Fino Saude Veterinary Drug Product
Table 113. Ouro Fino Saude Recent Developments/Updates
Table 114. CAHIC Corporation Information
Table 115. CAHIC Description and Business Overview
Table 116. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. CAHIC Veterinary Drug Product
Table 118. CAHIC Recent Developments/Updates
Table 119. Orion Corporation Information
Table 120. Orion Description and Business Overview
Table 121. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Orion Veterinary Drug Product
Table 123. Orion Recent Developments/Updates
Table 124. Ringpu Biology Corporation Information
Table 125. Ringpu Biology Description and Business Overview
Table 126. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Ringpu Biology Veterinary Drug Product
Table 128. Ringpu Biology Recent Developments/Updates
Table 129. Nippon Zenyaku Kogyo Corporation Information
Table 130. Nippon Zenyaku Kogyo Description and Business Overview
Table 131. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Nippon Zenyaku Kogyo Veterinary Drug Product
Table 133. Nippon Zenyaku Kogyo Recent Developments/Updates
Table 134. Farmavet-Pasteur Corporation Information
Table 135. Farmavet-Pasteur Description and Business Overview
Table 136. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Farmavet-Pasteur Veterinary Drug Product
Table 138. Farmavet-Pasteur Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Veterinary Drug Distributors List
Table 142. Veterinary Drug Customers List
Table 143. Veterinary Drug Market Trends
Table 144. Veterinary Drug Market Drivers
Table 145. Veterinary Drug Market Challenges
Table 146. Veterinary Drug Market Restraints
Table 147. Global Veterinary Drug Sales Forecast by Type (2023-2028) & (M Units)
Table 148. Global Veterinary Drug Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Veterinary Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Veterinary Drug Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Veterinary Drug Sales Forecast by Application (2023-2028) & (M Units)
Table 152. Global Veterinary Drug Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Veterinary Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Veterinary Drug Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Veterinary Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 156. Global Veterinary Drug Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Veterinary Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Veterinary Drug Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Veterinary Drug
Figure 2. Global Veterinary Drug Market Share by Type in 2021 & 2028
Figure 3. Anti-Infectives Product Picture
Figure 4. Anti-Inflammatory Product Picture
Figure 5. Parasiticides Product Picture
Figure 6. Analgesics Product Picture
Figure 7. Sedatives Product Picture
Figure 8. Others Product Picture
Figure 9. Global Veterinary Drug Market Share by Application in 2021 & 2028
Figure 10. Pets
Figure 11. Cattle
Figure 12. Poultry
Figure 13. Swine
Figure 14. Others
Figure 15. Global Veterinary Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Veterinary Drug Market Size (2017-2028) & (US$ Million)
Figure 17. Global Veterinary Drug Sales (2017-2028) & (M Units)
Figure 18. Veterinary Drug Sales Share by Manufacturers in 2021
Figure 19. Global Veterinary Drug Revenue Share by Manufacturers in 2021
Figure 20. The Global 5 and 10 Largest Veterinary Drug Players: Market Share by Revenue in 2021
Figure 21. Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Veterinary Drug Sales Market Share by Region (2017-2022)
Figure 23. Global Veterinary Drug Sales Market Share by Region in 2021
Figure 24. Global Veterinary Drug Revenue Market Share by Region (2017-2022)
Figure 25. Global Veterinary Drug Revenue Market Share by Region in 2021
Figure 26. U.S. Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Canada Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Germany Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. France Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. U.K. Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Italy Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Russia Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Japan Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. South Korea Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. India Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Australia Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Taiwan Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Indonesia Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Thailand Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Malaysia Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Philippines Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Vietnam Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Mexico Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Brazil Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Argentina Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Turkey Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Saudi Arabia Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. UAE Veterinary Drug Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Sales Market Share of Veterinary Drug by Type (2017-2022)
Figure 51. Manufacturing Cost Structure of Veterinary Drug
Figure 52. Manufacturing Process Analysis of Veterinary Drug
Figure 53. Veterinary Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’